1.3 Cellular Phases of Wound Healing and Diabetic Pathophysiologic Impairments

The Four Classical Phases of Wound Healing

Wound healing is an intricate, highly coordinated physiological cascade requiring the orchestration of soluble cytokines, growth factors, circulating blood elements, extracellular matrix (ECM) molecules, and resident parenchymal cells. Physiological wound healing is divided into four sequential, overlapping phases: hemostasis, inflammation, proliferation, and remodeling (maturation).

HEMOSTASIS          INFLAMMATION         PROLIFERATION          REMODELING
(0 to 24 hours)     (Day 1 to Day 4-6)   (Day 4 to Day 21)      (Day 21 to 1-2 Yrs)
===================================================================================> TIME
* Platelet plug     * Neutrophil influx  * Angiogenesis (VEGF)  * Collagen III -> I
* Fibrin matrix     * M1 Macrophages     * Fibroblasts (Coll.III)* Lysyl crosslinking
* PDGF, TGF-beta    * M1-to-M2 switch    * Granulation tissue   * 80% tensile max
* Vasoconstriction  * Phagocytosis/NETs  * Re-epithelialization * Scar pale/avascular

---

Phase 1: Hemostasis (Minutes to Hours Post-Injury)

Upon full-thickness disruptive injury to cutaneous tissue, the immediate primary objective is the prevention of exsanguination and the provisional sealing of the vascular breach:

1. Transient Vasoconstriction: Immediate reflex contraction of arteriolar smooth muscle mediated by sympathetic discharge and local vasoactive factors (endothelin-1, thromboxane A2, and norepinephrine). This temporary constriction lasts for 5 to 10 minutes, reducing local hemorrhage.
2. Platelet Adhesion and Activation: Platelets circulating through extravasated blood encounter exposed subendothelial Type IV collagen, von Willebrand factor (vWF), and fibronectin within the damaged vessel wall. Platelet surface receptors (glycoproteins Ib, IIb/IIIa, and VI) tether platelets to the exposed collagen, triggering platelet degranulation.
3. Provisional Fibrin-Fibronectin Scaffold: Activation of the extrinsic coagulation pathway via tissue factor (thromboplastin) leads to the conversion of prothrombin into thrombin. Thrombin enzymatically cleaves soluble circulating fibrinogen into insoluble fibrin monomers, which polymerize and are stabilized by factor XIIIa. This produces a cross-linked fibrin and fibronectin plug that halts bleeding and establishes a three-dimensional provisional matrix serving as a physical scaffold for subsequent cellular migration.
4. Cytokine Release from Alpha-Granules: Degranulating platelets discharge concentrated mitogens and chemoattractants from their alpha-granules into the wound milieu:
   • Platelet-Derived Growth Factor (PDGF): The primary, most potent chemoattractant for circulating neutrophils, monocytes, and tissue fibroblasts. It also stimulates early macrophage cytokine synthesis.
   • Transforming Growth Factor-Beta (TGF-β): Powerful chemotactic agent for inflammatory cells and the primary driver of subsequent fibroblast extracellular matrix and collagen synthesis.
   • Fibroblast Growth Factor (FGF) and Epidermal Growth Factor (EGF): Early primers for endothelial cell migration and keratinocyte activation.

---

Phase 2: Inflammation (Day 1 to Day 4–6)

Following provisional clot stabilization, local microvessels undergo active vasodilation and increased permeability mediated by histamine, serotonin, bradykinin, and prostaglandins (PGE2, PGI2). This allows plasma exudation and inflammatory leukocyte extravasation into the wound space.

1. Neutrophil (PMN) Extravasation and Function (First 24–48 Hours): Neutrophils are the first leukocytes to arrive at the injury site, recruited by PDGF, leukotriene B4 (LTB4), and bacterial formyl peptides. Neutrophils undergo a coordinated adhesion cascade: rolling (mediated by endothelial selectins E, P, and L), firm adhesion (mediated by neutrophil beta-2 integrins binding endothelial ICAM-1), and diapedesis (transmigration through intercellular endothelial junctions). Within the wound, neutrophils sterilize the bed by executing phagocytosis of bacteria and non-viable cellular debris. They kill engulfed microorganisms via an oxygen-dependent respiratory burst, where NADPH oxidase generates reactive oxygen species (ROS), including superoxide anions ($O_2^{\bullet-}$), hydrogen peroxide ($H_2O_2$), and hypochlorous acid ($HOCl$). Neutrophils also secrete proteolytic enzymes, notably neutrophil elastase and Matrix Metalloproteinase-8 (MMP-8, neutrophil collagenase), to digest damaged structural debris. Under normal physiological conditions, neutrophils complete their functional life cycle and undergo apoptosis within 48 to 72 hours, to be cleared by macrophages.

2. Monocyte Recruitment and the M1-to-M2 Macrophage Phenotypic Switch: At approximately 48 to 72 hours post-injury, blood-derived monocytes arrive under the influence of PDGF and MCP-1 (monocyte chemoattractant protein-1), extravasating into tissue and differentiating into tissue macrophages. The macrophage is widely considered the indispensable conductor of wound repair; depletion of macrophages halts repair. Macrophages display marked functional plasticity, characterized by a dynamic transition between two polarization states:

   • M1 Macrophages (Classically Activated / Pro-Inflammatory): Primed by interferon-gamma (IFN-γ), tumor necrosis factor-alpha (TNF-α), and bacterial lipopolysaccharide (LPS). M1 cells produce high levels of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6), generate high ROS and inducible nitric oxide synthase (iNOS), and secrete matrix metalloproteinases to continue debridement and bacterial elimination.
   • The M1-to-M2 Phenotypic Switch: As the bacterial and necrotic bioburden is successfully eliminated, macrophages ingest apoptotic neutrophils via a receptor-mediated process called efferocytosis. The engulfment of apoptotic bodies signals the macrophage genome to downregulate pro-inflammatory transcription factors and execute a phenotypic switch to the M2 phenotype.
   • M2 Macrophages (Alternatively Activated / Pro-Healing & Reparative): Induced by IL-4, IL-13, and efferocytic signaling. M2 macrophages downregulate catabolic enzymes and release regenerative cytokines, including VEGF, FGF-2, TGF-β, and PDGF. The emergence of the M2 phenotype is the biological checkpoint required to terminate the inflammatory phase and initiate the proliferative phase.

---

Phase 3: Proliferation (Day 4 to Day 21)

The proliferative phase focuses on structural restoration: reconstructing the lost tissue volume with vascularized stroma and restoring the epithelial barrier.

1. Angiogenesis (Neovascularization): The deep wound core is profoundly hypoxic (tissue $PO_2 < 15\text{ mmHg}$) and acidotic due to metabolic consumption and severed capillaries. Hypoxia stabilizes the intracellular transcription factor Hypoxia-Inducible Factor-1 Alpha (HIF-1α), which translocates to the nucleus to drive the transcription of Vascular Endothelial Growth Factor (VEGF). VEGF, alongside basic FGF (bFGF), stimulates resting endothelial cells in adjacent intact venules to digest their basement membrane, sprout capillary buds, migrate along the fibronectin scaffold, and anastomose into new loop-capillary networks. Pericytes subsequently envelop these sprouts, stabilizing mature capillaries.
2. Fibroplasia and Granulation Tissue Formation: Resident tissue fibroblasts migrate into the provisional fibrin-fibronectin matrix in response to PDGF and TGF-β. Fibroblasts proliferate and synthesize immense quantities of new, amorphous ECM rich in glycosaminoglycans (hyaluronic acid, which retains water to form a gel-like hydrated cushion) and proteoglycans. Simultaneously, activated fibroblasts synthesize and deposit large amounts of Type III collagen—a thin, pliable, delicate collagen isoform. The resulting combination of budding capillary loops, proliferating fibroblasts, and loose Type III collagen matrix constitutes beefy-red, translucent granulation tissue.
3. Re-Epithelialization: To re-establish the environmental barrier, intact basal keratinocytes from the wound margins and undamaged dermal adnexa (eccrine duct linings) detach from their underlying basement membrane. Keratinocytes downregulate hemidesmosomes, alter their integrin profile, flatten, and migrate across the freshly vascularized granulation bed—a process called epiboly. Keratinocytes advance as a migrating sheet, guided by the provisional matrix and stimulated by Epidermal Growth Factor (EGF), Keratinocyte Growth Factor (KGF / FGF-7), and TGF-alpha. Keratinocytes secrete matrix metalloproteinases (particularly MMP-1, collagenase-1) to dissolve non-viable fibrin obstructions ahead of their advancing edge. Once migrating keratinocytes from opposing wound borders achieve physical contact, contact inhibition arrests further horizontal migration. The cells then anchor to the newly reconstituted basement membrane (via laminin-332 and Type IV/VII collagen) and undergo vertical stratification and differentiation into a multilayered cornified epidermis.
4. Wound Contraction: Under the persistent influence of TGF-β1 and mechanical tension, a subset of specialized fibroblasts differentiates into myofibroblasts. Myofibroblasts express cytoplasmic alpha-smooth muscle actin (α-SMA) microfilaments. These contractile cells anchor their intracellular actin cytoskeleton to extracellular fibronectin fibrils via specialized focal adhesion complexes termed fibronexus. Through coordinated cell contraction, myofibroblasts pull the margins of the wound inward toward the center, reducing the open surface area by up to 40% to 70%.

---

Phase 4: Remodeling and Maturation (Day 21 Up to 1–2 Years)

The final phase represents the prolonged structural maturation of the repaired tissue:

1. Collagen Turnover and Subtype Replacement: During the early proliferative phase, the ratio of Type I to Type III collagen in granulation tissue is approximately 2:1 or 3:1 (in contrast to 4:1 or 5:1 in uninjured adult dermis). During remodeling, immature Type III collagen is systematically and selectively degraded by matrix metalloproteinases (collagenases) and replaced by synthesized Type I collagen, which forms much thicker, organized, parallel fibrils.
2. Covalent Cross-Linking and Structural Organization: Fibroblasts and myofibroblasts orient along lines of mechanical tension. The extracellular enzyme lysyl oxidase catalyzes covalent intermolecular cross-linking between lysine and hydroxylysine residues in adjacent collagen molecules. This biochemical cross-linking confers immense structural rigidity and tensile strength to the mature scar.
3. Vascular Regression: Once collagen remodeling progresses, the metabolic demands of the tissue decline. Dense capillary networks undergo widespread, programmed apoptosis (endothelial involution). The florid, beefy-red granulation tissue transforms into a relatively avascular, pale, flat scar.
4. Tensile Strength Plateau: At the completion of the proliferative phase (approximately 3 weeks), the wound possesses only 20% of its pre-injury tensile strength. By 3 months, through continuous collagen remodeling and covalent cross-linking, tensile strength rises to approximately 70%. The ultimate maximum tensile strength of a healed cutaneous scar never exceeds approximately 70% to 80% of original, uninjured skin. The repaired tissue remains permanently more vulnerable to recurrent mechanical breakdown under identical shear or compressive stresses.

---

Diabetic Pathophysiologic Impairments: The Molecular Arrest of Healing

In the person living with diabetes mellitus, this finely tuned repair program fails. Diabetic foot ulcers do not proceed smoothly through the classical phases; instead, they become trapped in a self-sustaining, pathological, hyper-inflammatory state, failing to progress to proliferation.

+-------------------------------------------------------------------------+
|               MOLECULAR ARREST IN CHRONIC DIABETIC ULCERS               |
+-------------------------------------------------------------------------+
|  PERSISTENT HYPERGLYCEMIA                                               |
|     |                                                                   |
|     v                                                                   |
|  Accumulation of Advanced Glycation End-products (AGEs)                 |
|     |                                                                   |
|     v                                                                   |
|  Sustained RAGE Binding on Endothelium, Macrophages & Fibroblasts       |
|     |                                                                   |
|     +---> NF-kB Activation: Unrelenting TNF-alpha, IL-1beta, IL-6       |
|     |                                                                   |
|     +---> Impaired Efferocytosis: MACROPHAGES TRAPPED IN M1 STATE       |
|     |                                                                   |
|     +---> Exaggerated NETosis: Neutrophil Extracellular Traps Destabilize|
|     |                                                                   |
|     v                                                                   |
|  MASSIVE MMP OVEREXPRESSION (MMP-2, MMP-8, MMP-9) + DEFICIENT TIMPs     |
|     |                                                                   |
|     v                                                                   |
|  - Proteolytic Destruction of Newly Synthesized Extracellular Matrix    |
|  - Enzymatic Cleavage of Endogenous Growth Factors (VEGF, PDGF, EGF)    |
|  - Premature Cellular Senescence of Fibroblasts & Endothelial Cells     |
|     |                                                                   |
|     v                                                                   |
|  STALLED, NON-HEALING CHRONIC ULCER CRATER (Slough, Exudate, No Edge)   |
+-------------------------------------------------------------------------+

1. The AGE-RAGE Signaling Axis

Persistent systemic hyperglycemia drives non-enzymatic condensation reactions between circulating glucose molecules and amino groups on proteins, structural collagens, and cell-surface receptors (the Maillard reaction), forming irreversible Advanced Glycation End-products (AGEs).

• AGEs directly form abnormal intermolecular cross-links within dermal collagen fibers, rendering the capillary basement membranes rigid, thickened, and impermeable.
• Circulating and matrix-bound AGEs bind to the Receptor for Advanced Glycation End-products (RAGE) present on monocytes, macrophages, endothelial cells, and fibroblasts. RAGE ligation triggers intracellular kinase cascades that permanently activate the master pro-inflammatory transcription factor NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells).
• Activated NF-κB directs constitutive, unceasing transcription and secretion of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) and sustained bursts of intracellular reactive oxygen species (ROS).

2. Arrested M1 Macrophages and Impaired Efferocytosis

In normal wounds, phagocytosis of apoptotic neutrophils by macrophages (efferocytosis) induces the phenotypic transition from the catabolic M1 phenotype to the reparative M2 phenotype. In the diabetic wound environment:

• High glucose and oxidative stress paralyze macrophage scavenger receptors (such as MerTK and CD36), severely blunting efferocytosis.
• Un-phagocytosed apoptotic neutrophils undergo secondary necrosis, releasing toxic granular proteases (elastase, cathepsin G) and intracellular contents directly into the extracellular matrix.
• Lacking efferocytic signaling and perpetually stimulated by AGEs and endotoxins, macrophages may remain biased toward a persistent pro-inflammatory phenotype. They continue to churn out cytotoxic cytokines, sustaining tissue catabolism and failing to generate the M2-dependent growth factor signals (VEGF, PDGF, TGF-β) required to stimulate fibroblast migration and capillary sprouting.

3. Exaggerated NETosis

In a hyperglycemic and cytokine-rich environment, diabetic neutrophils undergo an abnormal, suicidal cell death pathway known as NETosis. During NETosis, neutrophils extrude Neutrophil Extracellular Traps (NETs)—decondensed webs of nuclear chromatin (DNA and histones) impregnated with granular bactericidal enzymes (elastase, myeloperoxidase, MMP-8). While NETs evolved to ensnare circulating pathogens, excessive, unresolved NETosis in diabetic wounds forms toxic intraluminal microvascular thrombi, occludes capillary perfusion, directly damages adjacent stromal cells, and fuels persistent inflammation.

4. Elevated MMP-to-TIMP Ratio

A primary molecular hallmark of diabetic wound chronicity is a profound, destructive imbalance between Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of Metalloproteinases (TIMPs).

• In healthy acute healing, MMP levels spike transiently to clear debris and allow matrix restructuring, regulated tightly by endogenous TIMPs (such as TIMP-1 and TIMP-2) in a 1:1 stoichiometric ratio.
• In chronic diabetic foot ulcers, unceasing TNF-α and IL-1β stimulation causes neutrophils and M1 macrophages to synthesize pathological levels of proteases. Levels of collagenases (MMP-1, MMP-8) and gelatinases (MMP-2, MMP-9) are often elevated relative to acute healing wounds.
• Concurrently, local production of protective TIMPs is severely depressed.
• This overwhelming protease excess digests not only non-viable tissue, but indiscriminately cleaves newly deposited Type III collagen, degrades provisional fibronectin and vitronectin scaffolding, and destroys cell-surface integrin receptors on advancing keratinocytes. Most crucially, hyperactive MMPs enzymatically cleave endogenous and topically applied growth factors (such as PDGF, VEGF, and EGF) into inactive peptide fragments before they can bind to cellular receptors, rendering the wound bed biochemically refractory to reparative signaling.

5. Cellular Senescence and Endothelial Dysfunction

Resident fibroblasts and microvascular endothelial cells in chronic diabetic wounds exhibit premature cellular senescence (a state known as "phenotypically exhausted" or senescent cells). Under the cumulative insult of chronic hyperglycemia, oxidative DNA damage, and telomere shortening:

• Senescent fibroblasts fail to respond to mitogenic PDGF stimulation, exhibit impaired migratory velocity, synthesize minimal collagen, and adopt a Senescence-Associated Secretory Phenotype (SASP) that pumps additional degrading proteases into the stroma.
• Endothelial cells suffer from uncoupling of endothelial nitric oxide synthase (eNOS). Rather than producing vasoprotective nitric oxide (NO) for microvascular vasodilation and capillary perfusion, uncoupled eNOS produces damaging peroxynitrite and superoxide radicals, worsening local tissue ischemia and microvascular thrombosis.

---

Comparison: Acute Healing vs. Chronic Diabetic Ulcer Microenvironment